Skip to main content
Top
Published in: Critical Care 1/2016

Open Access 01-12-2016 | Editorial

Your critical care patient may have HLH (hemophagocytic lymphohistiocytosis)

Authors: Rafal Machowicz, Gritta Janka, Wieslaw Wiktor-Jedrzejczak

Published in: Critical Care | Issue 1/2016

Login to get access

Excerpt

Among various actions taken to improve the prognosis of critical care patients, an important step is including hemophagocytic lymphohistiocytosis (HLH; hemophagocytic syndrome) in the differential diagnosis. …
Literature
1.
go back to reference Henter J-I et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48:124–31.CrossRefPubMed Henter J-I et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48:124–31.CrossRefPubMed
2.
go back to reference Cetica V et al. Genetic predisposition to hemophagocytic lymphohistiocytosis: report on 500 patients from the Italian registry. J Allergy Clin Immunol. 2016;137:188–96. e4.CrossRefPubMedPubMedCentral Cetica V et al. Genetic predisposition to hemophagocytic lymphohistiocytosis: report on 500 patients from the Italian registry. J Allergy Clin Immunol. 2016;137:188–96. e4.CrossRefPubMedPubMedCentral
5.
go back to reference François B et al. Thrombocytopenia in the sepsis syndrome: role of hemophagocytosis and macrophage colony-stimulating factor. Am J Med. 1997;103:114–20.CrossRefPubMed François B et al. Thrombocytopenia in the sepsis syndrome: role of hemophagocytosis and macrophage colony-stimulating factor. Am J Med. 1997;103:114–20.CrossRefPubMed
6.
go back to reference Strauss R et al. Multifactorial risk analysis of bone marrow histiocytic hyperplasia with hemophagocytosis in critically ill medical patients—a postmortem clinicopathologic analysis. Crit Care Med. 2004;32:1316–21.CrossRefPubMed Strauss R et al. Multifactorial risk analysis of bone marrow histiocytic hyperplasia with hemophagocytosis in critically ill medical patients—a postmortem clinicopathologic analysis. Crit Care Med. 2004;32:1316–21.CrossRefPubMed
7.
go back to reference La Rosée P. Treatment of hemophagocytic lymphohistiocytosis in adults. Hematology Am Soc Hematol Educ Program. 2015;2015:190–6.PubMed La Rosée P. Treatment of hemophagocytic lymphohistiocytosis in adults. Hematology Am Soc Hematol Educ Program. 2015;2015:190–6.PubMed
8.
go back to reference Janka GE, Lehmberg K. Hemophagocytic lymphohistiocytosis: pathogenesis and treatment. Hematology Am Soc Hematol Educ Program. 2013;2013:605–11.PubMed Janka GE, Lehmberg K. Hemophagocytic lymphohistiocytosis: pathogenesis and treatment. Hematology Am Soc Hematol Educ Program. 2013;2013:605–11.PubMed
9.
go back to reference Imashuku S et al. Requirement for etoposide in the treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. J Clin Oncol. 2001;19:2665–73.PubMed Imashuku S et al. Requirement for etoposide in the treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. J Clin Oncol. 2001;19:2665–73.PubMed
Metadata
Title
Your critical care patient may have HLH (hemophagocytic lymphohistiocytosis)
Authors
Rafal Machowicz
Gritta Janka
Wieslaw Wiktor-Jedrzejczak
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Critical Care / Issue 1/2016
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/s13054-016-1369-3

Other articles of this Issue 1/2016

Critical Care 1/2016 Go to the issue